NEW YORK (AP) -- Medical device maker Integra LifeSciences said Thursday that it has resolved a mold problem at a collagen manufacturing facility in Plainsboro, N.J.
In December 2011, the Food and Drug Administration sent Integra a warning letter about mold in the facility, saying it could affect the company's products. The company first discovered visible mold there in June 2009. Integra said the FDA inspected the facility again in August and determined that the company's response was adequate. The warning was officially closed out on Tuesday, the company said.
Integra said the warning didn't affect its ability to make or sell any products. However in April the company announced a recall of collagen products because of problems at a facility in Puerto Rico. Integra said some of the products might not meet approved manufacturing standards.
Integra LifeSciences Holdings Corp. shares rose 38 cents to $39.03 in morning trading. They have traded in a 52-week range of $30.87 to $44.53.